Verition Fund Management
CSII

Verition Fund Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Verition Fund Management’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-7,500
Closed -$211K – 1322
2017
Q3 		$211K Buy
+7,500
New +$228K 0.02% 1045

Other funds holding CSII

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Frontier Capital Management
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Verition Fund Management's CSII Position: Q4 2017 in Review

Verition Fund Management sold out of Cardiovascular Systems, Inc. (CSII) in Q4 2017, closing a stake of 7,500 shares — an estimated $211K sold.

Verition Fund Management first reported a position in CSII in Q3 2017 and held it in 1 quarter. The position peaked at $211K in Q3 2017. 134 funds tracked by Wall St. Rank hold CSII as of Q4 2017.

  • Verition Fund Management reported no remaining Cardiovascular Systems, Inc. position as of Q4 2017 after selling out during the quarter.
  • Verition Fund Management sold 7,500 Cardiovascular Systems, Inc. shares in Q4 2017, an estimated $211K.
  • Verition Fund Management first reported a position in Cardiovascular Systems, Inc. in Q3 2017 and held it in 1 quarter.
  • Verition Fund Management's Cardiovascular Systems, Inc. position peaked at $211K in Q3 2017.
  • 134 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2017.

Based on Verition Fund Management's 13F filing for Q4 2017, filed 15 Feb 2018.